<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=234748540252369&amp;ev=PageView&amp;noscript=1">

Quantify Retinal Function.
Manage Retinal Disease.

Retina Plus Product Photo.jpg

Diopsys® RETINA PLUS, the most advanced flicker electroretinography (ERG) system, will help you detect and manage retinal disorders including diabetic retinopathy, CRVO, uveitis, and retinal concerns obscured by media opacities.1-5

  • Monitor treatment response with objective, functional information about global retinal health.1,2,5
  • Scalable to create a complete visual electrophysiology suite with:
    • Multifocal Electroretinography (mfERG)
    • Full Field / Flash Electroretinography (ffERG)
    • Pattern Electroretinography (pERG)
    • Visual Evoked Potential (VEP)
  • Custom carry case included allows testing in any clinical setting.

Fill in the form to get more details on this exciting new visual electrophysiology platfom.

Objective, functional results for you.
Enhanced care for your patients.

1. Yasuda S, et al. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Acta Ophthalmol. 2015;93:e465-8. 2. Moschos MM, et al. Electrophysiological examination in uveitis: a review of the literature. Clin Ophthalmol. 2014;8:199-214. 3. Larsson J, Andréasson S. Photopic 30 Hz flicker ERG as a predictor for Rubeosis in central retinal vein occlusion. Br J Ophthalmol. 2001;85:683-5. 4. Ratanapakorn T, et al. Effect of cataract on electroretinographic response. J Med Assoc Thai. 2010 Oct;93(10):1196-9. 5. Holm K, et al. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema. Doc Ophthalmol. 2015;131:43-51. 6. Dettoraki M, Moschos MM. The Role of Multifocal Electroretinography in the Assessment of Drug-Induced Retinopathy: A Review of the Literature. Ophthalmic Res 2016;56:169–177. 7. Talamini CL, et al. Abnormal multifocal ERG findings in patients with normal-appearing retinal anatomy. Doc Ophthalmol 2011;123(3):187-192. 8. Marmor, M, et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 2016;123:6:1386-1394. 9. Ventura LM, et al. The Relationship between Retinal Ganglion Cell Function and Retinal Nerve Fiber Thickness in Early Glaucoma. Invest Ophthalmol Vis Sci. 2006;47:3904–3911
The Diopsys® NOVA is an electrophysiology device that generates photic stimuli, and records, processes, and analyzes the resultant signals to provide information about the visual system. Diopsys Vision Testing Systems are FDA 510(k) cleared; carry the CE mark; and are IEC 60601 Certified.